S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AIM AIM ImmunoTech Inc

0.155

-0.0251 (-13.94%)

After Hours

Last Updated: 11:01:04

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech Inc News

Form 8-K - Current report
Thursday 6 February 2025 (11 hours ago) • Edgar (US Regulatory)

Erasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
Thursday 6 February 2025 (11 hours ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (2 days ago) • Edgar (US Regulatory)

AIM ImmunoTech Announces Publication of Final Clinical Study Results for AMP-518 Clinical Trial on Ampligen as a Therapeutic for Post-COVID Conditions
Friday 24 January 2025 (2 weeks ago) • GlobeNewswire Inc.

AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
Thursday 23 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 18 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 18 January 2025 (3 weeks ago) • Edgar (US Regulatory)

AIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving Milestones
Thursday 16 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

More AIM ImmunoTech Inc News Articles

Gold vs US Dollar

National Australia Bank

S&P ASX 300 Metals and M...

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions